期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
中西医结合治疗SARS的临床疗效观察 被引量:13
1
作者 李秀惠 张可 +4 位作者 胡建华 郭新会 胡中杰 扬宇 梁连春 《中国中西医结合杂志》 CAS CSCD 北大核心 2003年第7期489-491,共3页
目的:分析中西结合治疗严重急性呼吸综合征(SARS)的疗效。方法:对2003年3月11日—4月30日在我院用中西医结合治疗(中西医组)的65例SARS患者,并与单用西药治疗(西药组)的37例作对照,还测定了T细胞亚群(CD_4^+)。结果:中西医组65例,其中... 目的:分析中西结合治疗严重急性呼吸综合征(SARS)的疗效。方法:对2003年3月11日—4月30日在我院用中西医结合治疗(中西医组)的65例SARS患者,并与单用西药治疗(西药组)的37例作对照,还测定了T细胞亚群(CD_4^+)。结果:中西医组65例,其中普通型52例,治愈51例(98.1%),好转1例;重型13例,治愈9例(69.2%),好转2例(15.4%),死亡2例(15.4%)。西药组37例,其中普通型18例,治愈16例(88.9%),好转2例;重型19例,治愈10例(52.6%),死亡9例(47.4%),两组比较差异接近显著性(P=0.061)。CD_4^+:普通型患者中西医组治疗前为(360±247)个细胞/μl,治疗后为(563±479)个细胞/μl(P<O.05),西药组治疗前为(331±193)细胞个/μl,治疗后为(772±354)细胞个/μl(P<O.05);重型患者CD_4^+两组治疗前后比较差异均无显著性(P>0.05),中西医组治疗前后CD_4^+差值显著高于西药组(P<0.05)。结论:初步观察中西医结合治疗在改善SARS患者的预后,降低患者的病死率有影响,同时能帮助患者恢复免疫功能。 展开更多
关键词 严重急性呼吸综合症 中西医结合治疗 胸腺肽 左克 甲基强的松龙 醒脑注射药 参麦注射 生脉注射
下载PDF
Compatible stability study of Xing NaoJing injection based on physical-chemical properties analysis
2
作者 Dong-Li Qi Chun-Xia Liang +6 位作者 Yue-Lin Zhang Yan-Quan Gao Yue Xing Hong-Li Yan Bing Zhang Jia-Rong Xie Zhi-Dong Liu 《TMR Modern Herbal Medicine》 2019年第4期173-182,共10页
Objective:The clinical treatment of brain diseases is urgent. Xingnaojing (XNJ) injection is often used in combination with other injection drugs. Due to the possible interaction between the injections in vivo, the pa... Objective:The clinical treatment of brain diseases is urgent. Xingnaojing (XNJ) injection is often used in combination with other injection drugs. Due to the possible interaction between the injections in vivo, the particle size, osmotic pressure, pH value change and component stability decrease, that is one of the important factors causing various adverse reactions. Based on the above situation, this study investigated the physical properties and chemical composition changes of XNJ injection and its compatibility solvent and 13 kinds of clinical injection, speculated the possible interactions between the drugs in vivo from the perspective of in vitro compatibility stability, find out the safety risks of adverse reactions and provide guidance for the safe and rational use of XNJ injection. Methods:According to the clinical application, XNJ injection was mixed with 13 combination injections based on 250 mL 5% glucose injection, and placed at room temperature for 6 h. Then, the clarity, particle size, pH, osmolality, and the contents of camphor, d-borneol, and muscone of the compatible solutions were detected at 0, 1, 2, 4, and 6 h, respectively. Results:The results showed that the physical-chemical properties of compatibility solution were slightly influenced when XNJ was combined with Alprostadil injection and Danhong injection. The change of particle size and the degradation of muscone content were the main factors affecting the compatibility stability of XNJ injection, indicating that there are some problems in compatibility stability, which may be one of the causes of clinical adverse reactions. Conclusion:This study suggests that XNJ injection in combination with other injections during intravenous administration should be performed cautiously. 展开更多
关键词 Xingnaojing injection STABILITY Compatibility Physical-chemical properties Adverse drug reaction MUSCONE d-borneol
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部